EGFR and non-small cell lung carcinoma: The Guidelines for Clinical Practice of Molecular Tests in Non-Small Cell Lung Cancer in China (2024) stated that, in practical clinical settings, during the comprehensive analysis of acquired resistance to EGFR-TKIs, detection of NTRK fusion status is of particular importance (10).